- $23.62m
- $29.86m
- $0.34m
Annual cashflow statement for Clene., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.3 | -9.74 | -29.9 | -49.5 | -39.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2 | -26.3 | -8.68 | 17.5 | 13.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.87 | 0.703 | -1.43 | 0.159 | 3.35 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18.9 | -34.6 | -39 | -30.2 | -21.3 |
| Capital Expenditures | -0.387 | -1.33 | -5.18 | -0.33 | -0.015 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -4.99 | -1.17 | 6.33 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.387 | -1.33 | -10.2 | -1.5 | 6.32 |
| Financing Cash Flow Items | -4.01 | 6.82 | -0.081 | -0.2 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 69.5 | 27.1 | 17.2 | 42.2 | -1.53 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 50.5 | -8.93 | -32 | 10.5 | -16.7 |